Suchergebnisse - (Person:"Aggarwal, Saurabh")

PubPharm (7)

1

Cardiovascular Safety of Potential Drugs for the Treatment of Coronavirus Disease 2019

enthalten in: The American journal of cardiology | 2020

von Aggarwal, G. | Henry, B. | Aggarwal, S. | +1

CommentIn: Am J Cardiol. 2020 Sep 1;130:162-163. - PMID 32624192

2

Asymmetric dimethylarginine induces endothelial nitric-oxide synthase mitochondrial redistribution through the nitration-mediated activation of Akt1

enthalten in: The Journal of biological chemistry | 2013

von Rafikov, R. | Rafikova, O. | Aggarwal, S. | +5

3

Protein tyrosine phosphatase 1B inhibitors : a molecular level legitimate approach for the management of diabetes mellitus

enthalten in: Medicinal research reviews | 2012

von Thareja, S. | Aggarwal, S. | Bhardwaj, T. | +1

4

3D-QSAR studies on unsaturated 4-azasteroids as human 5alpha-reductase inhibitors : a self organizing molecular field analysis approach

enthalten in: European journal of medicinal chemistry | 2010

von Aggarwal, S. | Thareja, S. | Bhardwaj, T. | +1

5

An overview on 5alpha-reductase inhibitors

enthalten in: Steroids | 2010

von Aggarwal, S. | Thareja, S. | Verma, A. | +2

6

3D-QSAR studies on a series of 5-arylidine-2, 4-thiazolidinediones as aldose reductase inhibitors : a self-organizing molecular field analysis approach

enthalten in: Medicinal chemistry (Shariqah (United Arab Emirates)) | 2010

von Thareja, S. | Aggarwal, S. | Bhardwaj, T. | +1

7

Self organizing molecular field analysis on a series of human 5alpha-reductase inhibitors : unsaturated 3-carboxysteroid

enthalten in: European journal of medicinal chemistry | 2009

von Thareja, S. | Aggarwal, S. | Bhardwaj, T. | +1

1
[1]